Gsk (GSK) Return on Invested Capital (2015 - 2026)

Gsk's Return on Invested Capital history runs 12 years deep, the most recent figure standing at 0.06% for Q2 2026.

• In Q2 2026, Return on Invested Capital fell 6.0% year-over-year to 0.06%; the TTM figure through Jun 2026 stood at 0.06% (down 6.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q2 2026 stood at 0.06%, up from 0.06% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.07% in Q1 2023, with the low at 0.26% in Q3 2023.
• The 5-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.04%.
• The sharpest annual moves came in 2023 and 2024: Return on Invested Capital declined 27 bps in 2023, then rose 24 bps in 2024.
• Gsk's Return on Invested Capital stood at 0.02% in 2022, then tumbled by 988 bps to 0.15% in 2023, then jumped by 106 bps to 0.01% in 2024, then soared by 75 bps to 0.02% in 2025, then plunged by 464 bps to 0.06% in 2026.
• Business Quant data shows GSK's Return on Invested Capital at 0.06% in Q2 2026, 0.06% in Q1 2026, and 0.02% in Q4 2025.